metastasis
Thus, we conclude that the combination of an anti-HPA antibody and a CTL response in HPA-immunization gene therapy is enough to attenuate tumor growth and metastasis.
Thus, we conclude that the combination of an anti-<span class="gene" id="22240343-9-50-53">HPA</span> antibody and a CTL response in <span class="gene" id="22240343-9-85-88">HPA</span>-immunization gene therapy is enough to attenuate tumor growth and <span class="disease" id="22240343-9-155-165">metastasis</span>.